On February 3, 2023, the Antitrust Division of the Department of Justice (DOJ) withdrew its nearly 30-year-old guidance on information exchanges in the healthcare industry.
On February 3, 2023, the Antitrust Division of the US Department of Justice (DOJ) withdrew its support for three long-standing policy statements relating to enforcement
On February 2, 2023, Principal Deputy Assistant Attorney General Doha Mekki announced that the US Department of Justice (DOJ) Antitrust Division was revisiting and withdrawing several.